IL1B and gastric carcinoma: In the gastric carcinoma patients, IL-1B-511*T/T homozygous allele represented 15.6% (5/32) of the case subjects, which was proportionally higher than in control group (12.0%; 13/108), however statistically with an OR of 2.349 (95% CI: 0.583–9.462) was not confirmed.